Dow Down 0.92% Nasdaq Down 0.83%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
384.46 Up 3.45(0.91%) 4:00PM EDT
|After Hours : 384.20 Down 0.26 (0.07%) 6:20PM EDT
Prev Close:381.01
Open:380.06
Bid:384.20 x 200
Ask:390.00 x 200
1y Target Est:378.70
Beta:0.85
Next Earnings Date: 4-Nov-14REGN Earnings announcement
Day's Range:373.34 - 384.85
52wk Range:257.69 - 384.85
Volume:1,025,800
Avg Vol (3m):796,628
Market Cap:38.60B
P/E (ttm):109.41
EPS (ttm):3.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 0.91%38.60B
AMGNDown 0.31%109.11B
NVSDown 0.46%213.99B
RHHBYDown 0.10%247.03B

Key Statistics

Forward P/E (1 yr):31.08
P/S (ttm):15.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :10.13
Quarterly EPS Est (Sep-14) :2.57
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback